Testing Onco4D guidance to choose chemotherapy
Part of Cancer clinical trials.
This study looks at whether the Onco4D® test helps doctors pick the right chemotherapy and improves outcomes. You may be able to join if you have any confirmed cancer and your doctor orders the Onco4D® test for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have confirmed cancer based on lab-tissue testing (histology)
- Your treating doctor has ordered the Onco4D® test for you
- You are at least 18 years old when you sign consent
- You can understand the study and are willing to sign informed consent
- No other exclusion rules are listed for this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at your tumor (and blood) to find helpful targets so doctors can match you to an experimental targeted therapy, if one fits. It may help by using detailed “tumor profiling” to choose treatments more precisely for your cancer.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This trial checks whether a blood test can detect early signs of multiple cancers in people who feel well. It may help find cancer earlier, when treatment is more likely to work.
This study tests whether using the Oncogramme® device to guide the first-line treatment improves care for people with metastatic colorectal (colon/rectum) cancer. If the device helps pick the most suitable standard chemotherapy plan, it could lead to better outcomes than choosing without it.
This trial tests whether a blood test for ctDNA (cancer DNA fragments) can help doctors decide if standard chemotherapy plus an immunotherapy drug is working for people with advanced or recurrent endometrial cancer. It may help tailor your treatment based on how the cancer responds.
This study tests whether a special blood test (looking for cancer DNA) can help doctors decide if you need chemotherapy after colorectal cancer surgery. The goal is to avoid unnecessary chemotherapy while making sure patients who need it get treated.
Hear when a new Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.